We are live on ! Find out more
CIAM

Caitong International Asset Management Portfolio holdings

AUM $729M
1-Year Est. Return 1,176.98%
This Fund
S&P 500
This Quarter Est. Return
+11.82%
1 Year Est. Return
+1,176.98%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$408M
AUM Growth
+$264M
Cap. Flow
+$290M
Cap. Flow %
71.11%
Top 10 Hldgs %
42.15%
Holding
2,498
New
625
Increased
740
Reduced
453
Closed
660

Top Buys

Rank Stock Value
1
ONDS icon
Ondas Inc
ONDS
+$27.5M
2
TSLA icon
Tesla
TSLA
+$21.2M
3
CORT icon
Corcept Therapeutics
CORT
+$19.8M
4
MU icon
Micron Technology
MU
+$18.6M
5
RKLB icon
Rocket Lab Corp
RKLB
+$17.6M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$8.84M
2
WOLF icon
Wolfspeed
WOLF
+$6.68M
3
IONQ icon
IonQ
IONQ
+$4.85M
4
RGTI icon
Rigetti Computing
RGTI
+$3.55M
5
INTC icon
Intel
INTC
+$3.24M

Sector Composition

Rank Sector Weight
1 Technology 33.96%
2 Financials 15.19%
3 Consumer Discretionary 13.61%
4 Industrials 13.03%
5 Healthcare 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RIOT icon
2301
Riot Platforms
RIOT
$7.63B
-5,598
Closed -$107K
RITM icon
2302
Rithm Capital
RITM
$5.71B
-3,996
Closed -$45.5K
RMAX icon
2303
RE/MAX Holdings
RMAX
$263M
-1
Closed -$9
RMD icon
2304
ResMed
RMD
$32.8B
-24
Closed -$6.57K
RNW icon
2305
ReNew
RNW
$2.48B
-27
Closed -$208
ROP icon
2306
Roper Technologies
ROP
$39.1B
-291
Closed -$145K
RPD icon
2307
Rapid7
RPD
$827M
-8
Closed -$150
RTX icon
2308
RTX Corp
RTX
$300B
-1,164
Closed -$195K
RVTY icon
2309
Revvity
RVTY
$13.2B
-409
Closed -$35.8K
RXRX icon
2310
Recursion Pharmaceuticals
RXRX
$1.76B
-18,659
Closed -$91.1K
RYZ
2311
Ryerson Holding Corp
RYZ
$1.5B
-1
Closed -$23
SAFE
2312
Safehold
SAFE
$1.09B
-42
Closed -$651
SAH icon
2313
Sonic Automotive
SAH
$2.56B
-1
Closed -$76
SAM icon
2314
Boston Beer
SAM
$1.89B
-22
Closed -$4.65K
SB icon
2315
Safe Bulkers
SB
$760M
-1,245
Closed -$5.53K
SBAC icon
2316
SBA Communications
SBAC
$19.4B
-660
Closed -$128K
SBLK icon
2317
Star Bulk Carriers
SBLK
$3.11B
-86
Closed -$1.6K
SBRA icon
2318
Sabra Healthcare REIT
SBRA
$5.16B
-801
Closed -$14.9K
SCL icon
2319
Stepan Co
SCL
$1.48B
-119
Closed -$5.68K
SCLX icon
2320
Scilex Holding
SCLX
$48.5M
-174
Closed -$3.42K
SCPH
2321
DELISTED
scPharmaceuticals
SCPH
-218
Closed -$1.24K
SCS
2322
DELISTED
Steelcase
SCS
-2,374
Closed -$40.8K
SDGR icon
2323
Schrodinger
SDGR
$1.39B
-161
Closed -$3.23K
SFM icon
2324
Sprouts Farmers Market
SFM
$8.03B
-2,147
Closed -$234K
SGRY icon
2325
Surgery Partners
SGRY
$2.01B
-2,287
Closed -$49.5K

Similar funds

Caitong International Asset Management's Q4 2025 Portfolio in Review

As of Q4 2025, Caitong International Asset Management held 2,498 positions worth $408M, up 183% from $144M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Caitong International Asset Management deployed $290M of net new capital in Q4 2025, opening 625 new positions and adding to 740 existing holdings. Its largest new stake was Corcept Therapeutics: 251,632 shares worth $8.76M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 44% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was NVIDIA, an estimated $8.84M trimmed.

  • Caitong International Asset Management's largest Q4 2025 buy was Corcept Therapeutics: 251,632 shares worth $8.76M.
  • Caitong International Asset Management added most to Ondas Inc in Q4 2025, an estimated $27.5M increase.
  • Caitong International Asset Management's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $8.84M.
  • Caitong International Asset Management fully exited Tilray in Q4 2025, selling an estimated $1.72M.
  • Caitong International Asset Management's ten largest holdings make up 42% of its $408M portfolio in Q4 2025.
  • Caitong International Asset Management opened 625 new positions and closed 660 in Q4 2025.
  • Caitong International Asset Management's portfolio value rose 183% quarter-over-quarter to $408M.

Based on Caitong International Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.